Events in the Series

Deepen Scientific Understanding of Inflammatory & Fibrotic ILDs, Investigate Biomarkers to Stratify Trial Populations and Identify Endpoints Which are Likely to Predict Clinical Success in Your Next Clinical Trial
Returning in April 2023

Solving the Translational Drug Development Gap, From Fibroblast Heterogeneity to Clinically Successful Therapeutics
Returning in August 2023